Amgen is developing monthly GLP-1 injections aimed at improving convenience and long-term adherence for patients.
What to know about MariTide, Amgen's experimental GLP-1 drug
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!